Jane Street Group, LLC Ocular Therapeutix, Inc Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 353,812 shares of OCUL stock, worth $4.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

353,812

Previous 110,472 220.27%

Holding current value

$4.02 Million

Previous $1.03 Million 303.51%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$9.09 - $13.6 $2.21 Million - $3.31 Million	243,340 Added 220.27%	353,812 $4.14 Million
Q2 2025 Aug 14, 2025	BUY	$6.02 - $9.46 $32,646 - $51,301	5,423 Added 5.16%	110,472 $1.03 Million
Q1 2025 May 14, 2025	BUY	$5.93 - $9.08 $622,940 - $953,844	105,049 New	105,049 $770,000
Q3 2024 Nov 14, 2024	SELL	$6.45 - $9.23 $448,081 - $641,208	-69,470 Reduced 35.81%	124,542 $1.08 Million
Q2 2024 Aug 14, 2024	SELL	$4.2 - $8.69 $245,044 - $507,009	-58,344 Reduced 23.12%	194,012 $1.33 Million

Q1 2024 May 15, 2024	BUY	$3.85 - $10.93 $466,816 - $1.33 Million	121,251 Added 92.48%	252,356 $2.3 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $147,141 - $319,749	70,741 Added 117.19%	131,105 $584,000
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $618,278 - $992,396	-196,904 Reduced 76.54%	60,364 $189,000
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $645,021 - $1.07 Million	140,222 Added 119.8%	257,268 $1.33 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $249,490 - $560,682	89,423 Added 323.73%	117,046 $616,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $12,958 - $21,895	4,965 Added 21.91%	27,623 $77,000
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $99,329 - $157,859	-24,286 Reduced 51.73%	22,658 $94,000
Q2 2022 Aug 16, 2022	BUY	$3.01 - $5.22 $141,301 - $245,047	46,944 New	46,944 $189,000
Q1 2022 May 17, 2022	SELL	$4.83 - $7.35 $81,506 - $124,031	-16,875 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$6.16 - $12.07 $244,441 - $478,961	-39,682 Reduced 70.16%	16,875 $118,000
Q3 2021 Nov 16, 2021	BUY	$9.7 - $14.34 $138,341 - $204,517	14,262 Added 33.72%	56,557 $565,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $14,088 - $20,098	1,049 Added 2.54%	42,295 $599,000
Q1 2021 May 18, 2021	BUY	$15.82 - $22.11 $82,153 - $114,817	5,193 Added 14.4%	41,246 $677,000
Q4 2020 Feb 17, 2021	BUY	$7.91 - $22.95 $46,882 - $136,024	5,927 Added 19.67%	36,053 $746,000
Q3 2020 Nov 17, 2020	BUY	$7.36 - $9.87 $46,713 - $62,644	6,347 Added 26.69%	30,126 $229,000
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $93,927 - $175,964	23,779 New	23,779 $118,000
Q3 2018 Nov 14, 2018	SELL	$5.42 - $6.99 $73,110 - $94,288	-13,489 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$5.99 - $8.17 $80,799 - $110,205	13,489 New	13,489 $91,000

Others Institutions Holding OCUL

# of Institutions

235

Shares Held

157M

Call Options Held

1.24M

Put Options Held

423K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $875M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Ocular Therapeutix, Inc Transaction History